bazedoxifene has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, Z; Li, S; Tian, J; Wang, X; Yang, J; Zhang, H; Zhang, L; Zhang, Z; Zhou, S | 1 |
| Lai, YH; Li, C; Li, H; Lin, J; Ma, L; Wei, J; Zhang, R | 1 |
2 other study(ies) available for bazedoxifene and Colonic Neoplasms
| Article | Year |
|---|---|
Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cytokine Receptor gp130; Down-Regulation; Female; Fluorouracil; Humans; Indoles; Interleukin-6; Mice; Mice, Nude; Neoplasm Invasiveness; Selective Estrogen Receptor Modulators; Signal Transduction; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2018 |
Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy.
Topics: Cell Line, Tumor; Colonic Neoplasms; Cytokine Receptor gp130; Humans; Indoles; Selective Estrogen Receptor Modulators; Transfection | 2019 |